Heidelberg and Dortmund, Germany – The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify biomarkers that predict therapeutic response and the incidence of immune-related adverse events (irAEs) in urothelial carcinoma patients treated with checkpoint inhibitors. In recent years, checkpoint inhibitors have […]

Effort Designed to Safely and Efficiently Speed Drug Candidates into the Clinic Geneva, Switzerland – Selexis SA and Berkeley Lights, Inc. today announced a collaboration around the acquisition of Berkeley Lights’ Beacon® optofluidic platform. The partners will leverage the technology to accelerate cell line development (CLD) with the Selexis SUREtechnology Platform™. Selexis scientists have extensively evaluated the Beacon […]

Partnership will improve access to critical literature content and accelerate patient diagnosis OAKLAND, Calif. & ANN ARBOR, Mich.–Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further strengthening clinical genomic interpretation and variant […]

New partnership enables pharmaceutical and healthcare delivery companies with graph-based analytics capabilities for actionable insights BOSTON Cambridge Semantics, the leading provider of an enterprise data fabric, and Symbotix, a healthcare technology innovation and consultancy group, today announced a partnership that aims to help solve the most challenging data problems of modern healthcare enterprises. Today’s healthcare organizations […]

Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service Cambridge, United Kingdom – Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic Medicine Service. Genomics England […]

SAN DIEGO — Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, and Genoox, the healthcare technology company on a mission to make it easier for doctors, clinicians and researchers to run clinical genetic applications and act on […]

Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology Daresbury, UK: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a technology access agreement with Teleflex Incorporated, a New York Stock Exchange listed company (NYSE: TFX). Teleflex will harness Arcis’ advanced nucleic acid sample preparation chemistry in the […]

CAMBRIDGE, Mass. — Planetary Emissions Management Inc. (PEM) has signed a Memorandum of Understanding (MoU) with ABB’s Measurement & Analytics business unit, to explore commercial manufacturing of new laser-based technology for high precision measurement of 14CO2 in a benchtop portable instrument. The Radiocarbon Infrared Spectrometer (iRIS-III) technology was developed by the National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, and is licensed exclusively […]

AUSTIN, Texas VUV Analytics, Inc., pioneers in developing lab scale Vacuum Ultraviolet (VUV) based analytical instruments and Shimadzu, a leading manufacturer of analytical and medical instruments, today announced a Global Solutions Distribution agreement. The non-exclusive agreement combines the VGA gas chromatography detectors from VUV Analytics with the Shimadzu gas chromatography product line. Shimadzu Corporation, along with their […]